# Efficacy and Safety of High Dose Vitamin D Supplementation for Overactive Bladder Dry in Children

> **NCT05709990** · NA · COMPLETED · sponsor: **Xing Liu** · enrollment: 303 (actual)

## Conditions studied

- Overactive Bladder

## Interventions

- **DRUG:** Solifenacin Succinate 5 MG Oral Tablet [Vesicare]
- **DRUG:** Vitamin D3
- **BEHAVIORAL:** Standard urotherapy

## Key facts

- **NCT ID:** NCT05709990
- **Lead sponsor:** Xing Liu
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-01-15
- **Primary completion:** 2023-06-03
- **Final completion:** 2023-06-15
- **Target enrollment:** 303 (ACTUAL)
- **Last updated:** 2024-02-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05709990

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05709990, "Efficacy and Safety of High Dose Vitamin D Supplementation for Overactive Bladder Dry in Children". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05709990. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*